openPR Logo
Press release

Rabies Treatment Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2023

02-28-2017 10:15 PM CET | Health & Medicine

Press release from: Transparency Market Research – Pharmaceutical

Rabies Treatment Market Research Report by Regional Analysis -

Rabies is a zoonotic viral disease caused due to animal bits. The disease is known to affect domestic as well as wild animals such as bats, skunks, foxes, ferrets, raccoons, cats, or dogs, and infects humans upon contact with saliva of infected animal. Rabies is known to have an incubation period of one to three months. Individuals suffering from rabies show initial symptoms of fever and pain or tingling or burning sensation also called as paraesthesia at the wound site. As the disease progresses through the central nervous system (CNS), patients exhibit hyperactivity, excited behavior, hydrophobia. Rabies can also be paralytic and accounts for approximately 3% of all rabies cases globally according to World Health Organization (WHO). This form is usually misdiagnosed and has slower progression. Muscles near the wound site begin to paralyze; untreated infections lead to coma and cause death.

WHO statistics also show that although rabies is prevalent in all continents except Antarctica, more than 95% of the mortalities occur in African and Asian countries. Rabies infections are common in areas where human-animal interaction is more and no proper medical treatment facility is available for treatment. In the U.S. only 55 cases have been identified since 1955 according to Centers for Disease Control and Prevention (CDC). Rapid diagnostic tests are available for diagnosis of rabies. These tests are usually Enzyme Linked Immunosorbent Assay (ELISA) or fluorescent assay technology. Synbiotics Corporation, O.K. SERVIS BioPro, s.r.o., Bio-Rad Laboratories, Inc. and Alpha Diagnostic International are some of the players manufacturing diagnostic kits for rabies.

Browse full report on Rabies Treatment Market -

http://www.transparencymarketresearch.com/rabies-treatment-market.html

Novartis and Sanofi are key players in the global rabies treatment market. These companies manufacture prophylactic vaccines for humans. Sanofi’s Imovax Rabies is a human diploid cell vaccine; while Novartis’s RabAvert is a Purified chick embryo cell vaccine. Vaccines are also available for preventing infections in animals. Merial a Sanofi company announced in July 2014 had it has launched PUREVAX Feline Rabies 3 YR vaccine. This is a non-adjuvanted rabies vaccine and provides 3 year immunity. The vaccine has been recommended for immunization of healthy cats 12 weeks and older. Cadila Pharmaceuticals Ltd, is also working on development of new generation rabies vaccine in India. Under-developed countries have initiated mass vaccination of stray dogs to control mortalities. According to an article published by World Health Organization (WHO) in 2014, Kenya launched a nationwide program for vaccination of dogs. Currently, more than 3,000 dogs in Makueni County have been vaccinated. In September 2014, The Philippines Department of Agriculture (DA), the Australian Government and the World Organization for Animal Health (OIE) launched rabies control project to reduce rabies cases due to dog in the Philippines. Earlier in 2013, massive dog vaccination program was launched, which vaccinated 92,869 dogs and attained 80% coverage according to a press release by World Organization for Animal Health. An article published in The Maravi Post, Malawi also plans to vaccinate 500,000 dogs and cats to curb the rabies crisis. Such preventive programs will help in reducing the prevalence of the disease in lower socio-economic classes. With developing economic conditions and consistent government initiatives, the prevalence of rabies is expected to shrink in the future. Higher prevalence in the Asia Pacific and Africa provides larger customer base for players in the rabies treatment market.

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9022

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rabies Treatment Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2023 here

News-ID: 452680 • Views: 442

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html Diabetic macular edema is the major reason for loss of vision in patients
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs

All 5 Releases


More Releases for Rabies

Rabies Treatment Market Universal Demand Survey 2025
Global Rabies Treatment Market: Snapshot Earlier, widespread culling of animals was embarked upon to stamp out rabies – a fatal disease caused by rabies virus transmitted from animals to humans. Domestic dogs are mainly the carriers of the virus and over 95.0% of human deaths result from dog-mediated rabies, states WHO. It also finds that Asia and Africa account for almost 95.0% of the tens of thousands of rabies deaths occurring
Rabies Treatment Market broadly segmented by 2025
Global Rabies Treatment Market: Snapshot Earlier, widespread culling of animals was embarked upon to stamp out rabies – a fatal disease caused by rabies virus transmitted from animals to humans. Domestic dogs are mainly the carriers of the virus and over 95.0% of human deaths result from dog-mediated rabies, states WHO. It also finds that Asia and Africa account for almost 95.0% of the tens of thousands of rabies deaths occurring
Rabies Treatment Market - Global Industry Analysis, Size, Share 2023
The global rabies treatment market is anticipated to gain momentum in growth with three key factors driving the demand in the industry. The application of novel culture media to produce contamination-free vaccines and stringent regulatory examinations conducted by governments could be first on the list of important market drivers. There is a need to eliminate the risk of vaccine contamination due to the involvement of human components and bovine spongiform
Rabies Treatment Sales Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Rabies Treatment Sales Market Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-rabies-treatment-sales-market-report-2017-1541235 In this report, the global Rabies Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions,
Rabies Treatment Market | Analysis & Key Trends 2023
Global Rabies Treatment Market: Snapshot The global rabies treatment market is anticipated to gain momentum in growth with three key factors driving the demand in the industry. The application of novel culture media to produce contamination-free vaccines and stringent regulatory examinations conducted by governments could be first on the list of important market drivers. There is a need to eliminate the risk of vaccine contamination due to the involvement of human
Rabies Treatment Market - Detailed Analysis of Restrain and Growth Factors
Global Rabies Treatment Market: Overview Rabies is a neural disease caused by a virus. It affects humans and several other mammals, with dogs, bats, raccoons, and cats being among the most common victims. Rabies causes inflammation of the brain, leading to fever, loss of control over body parts, and a fear of water. Rabies treatment is a key concern despite the relatively limited spread of the disease, as rabies is almost